Two Sigma Investments’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $349K | Sell |
43,621
-3,130
| -7% | -$25K | ﹤0.01% | 2687 |
|
2025
Q1 | $456K | Buy |
46,751
+24,193
| +107% | +$236K | ﹤0.01% | 2498 |
|
2024
Q4 | $285K | Sell |
22,558
-42,495
| -65% | -$537K | ﹤0.01% | 2688 |
|
2024
Q3 | $1.05M | Sell |
65,053
-11,485
| -15% | -$185K | ﹤0.01% | 2034 |
|
2024
Q2 | $1.87M | Buy |
76,538
+23,338
| +44% | +$569K | ﹤0.01% | 1531 |
|
2024
Q1 | $3.82M | Buy |
53,200
+49,120
| +1,204% | +$3.53M | 0.01% | 1064 |
|
2023
Q4 | $811K | Buy |
4,080
+1,705
| +72% | +$339K | ﹤0.01% | 2121 |
|
2023
Q3 | $316K | Sell |
2,375
-3,450
| -59% | -$459K | ﹤0.01% | 2398 |
|
2023
Q2 | $871K | Sell |
5,825
-2,145
| -27% | -$321K | ﹤0.01% | 1945 |
|
2023
Q1 | $1.17M | Buy |
7,970
+5,395
| +210% | +$792K | ﹤0.01% | 1713 |
|
2022
Q4 | $408K | Buy |
+2,575
| New | +$408K | ﹤0.01% | 2055 |
|
2022
Q3 | – | Sell |
-1,475
| Closed | -$215K | – | 2698 |
|
2022
Q2 | $215K | Sell |
1,475
-8,374
| -85% | -$1.22M | ﹤0.01% | 2069 |
|
2022
Q1 | $1.73M | Sell |
9,849
-7,341
| -43% | -$1.29M | 0.01% | 1390 |
|
2021
Q4 | $5.05M | Sell |
17,190
-9,227
| -35% | -$2.71M | 0.01% | 905 |
|
2021
Q3 | $6.56M | Buy |
26,417
+1,060
| +4% | +$263K | 0.01% | 770 |
|
2021
Q2 | $6.45M | Buy |
25,357
+21,219
| +513% | +$5.4M | 0.01% | 809 |
|
2021
Q1 | $735K | Sell |
4,138
-1,350
| -25% | -$240K | ﹤0.01% | 1718 |
|
2020
Q4 | $867K | Buy |
5,488
+3,808
| +227% | +$602K | ﹤0.01% | 1402 |
|
2020
Q3 | $433K | Buy |
+1,680
| New | +$433K | ﹤0.01% | 1469 |
|